Company intelligence / Profile preview

MTIP

Basel, Basel-Stadt, Switzerland

Ownership: Private
Development stage: Other

Overview

MTIP is an active Swiss-based growth equity firm headquartered in Basel, specializing in investments in healthtech companies across Europe, focusing on digital health, digital pharma, and connected medical devices. It targets scale-up and growth-stage SaaS and health software businesses, investing in and scaling up companies developing healthtech solutions rather than developing clinical-stage therapies directly.

Industry: Investors

Partnerships

European Investment Fund (EIF)OvivaTrialbeeKoa HealthMediktorIntelligenciaHexaradDossier SolutionsCaresyntaxReactive RoboticsCoramazeBlueprint GeneticsLumeonCynerio

Beyond the preview

Go deeper on MTIP.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MTIP.

Explore the full profile